Proxima Therapeutics Receives US Patent For Device To Deliver Internal Radiation Therapy For Spinal Metastases
10/19/2005 5:11:35 PM
Proxima Therapeutics, Inc. today announced that the company has expanded its strong intellectual property portfolio with a recently issued second patent (US Patent # 6,749,555 B1) for delivery of brachytherapy for spinal metastases. The device design incorporates Proxima's proprietary inflatable balloon catheter technology currently in commercial use to deliver internal radiation therapy for breast and brain cancer. The spinal column is the most frequent site of bone metastasis in the body, and it is estimated that spinal metastases affect more than 100,000 individuals annually.
comments powered by